Live webcast examines why biotech IPOs are gaining momentum again
Drew Armstrong, executive editor at Endpoints News, announced a live webcast scheduled for July 15 at 12 p.m. ET. The session will feature Parabilis CEO Mathai Mammen and Kailera CEO Ron Renaut, along with IPO reporter Kyle LaHucik, to discuss recent biotech IPO activity.
After a slowdown in 2024 and 2025, more than a dozen biotech startups have gone public this year, suggesting a revival in market enthusiasm for new offerings.
The discussion will explore what is driving the steady flow of IPOs, how the current environment differs from earlier false starts, and what challenges public biotech companies may face as the rally evolves.
Viewers can watch the webcast on YouTube and add the event to their Google or Outlook calendars for a reminder.
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Post-Hoc Live: What’s making biotech IPOs work again?”
read at Endpoints ↗
comments(0)
5-min edit window · permanent after that